What Is the New EU Urban Wastewater Treatment Directive?

Overview

The new EU Urban Wastewater Treatment Directive is the recast framework for collecting, treating and discharging urban wastewater across the European Union. For wastewater treatment plant operators, municipalities and consulting engineers, the most important point is straightforward: the directive strengthens the long-term direction of travel for biological treatment, while retaining secondary treatment as the core compliance baseline for most agglomerations.

This article focuses on the secondary-treatment provisions that matter to plant planning and operations. It also places the directive in context so you can see where nutrient removal, micropollutant removal and energy neutrality sit in the wider regulatory picture.

If you are reviewing a specific plant or catchment, it is useful to map the legal obligations against the process configuration, hydraulic profile and future loading outlook. You can also Start the Engineering Assessment to structure that review.

What the new directive is

Directive (EU) 2024/3019 is the recast Urban Wastewater Treatment Directive. It entered into force on 1 January 2025.

Two dates are especially important for compliance planning:

• The old Directive 91/271/EEC is repealed with effect from 1 August 2027.
• Member States must transpose the new directive into national law by 31 July 2027.

For operators, this means that the EU-level framework is already in place, but the exact legal text applied at plant level will depend on national transposition and subsequent implementation. In practice, permit conditions, guidance and enforcement arrangements may differ between Member States, even though the core EU requirements are common.

What counts as secondary treatment

The directive defines secondary treatment as treatment that generally involves biological treatment with a secondary settlement stage, or another process that removes biodegradable organic matter.

That definition is broad enough to cover conventional activated sludge systems, extended aeration, oxidation ditch configurations, trickling filters, biofilm-based systems and other biological processes, provided they achieve the required removal of biodegradable organics. The common thread is that the process must reliably reduce the biodegradable fraction of the wastewater load.

For operators, the practical implications are familiar:

• Biological capacity must match current and future organic loading.
• Secondary clarification or equivalent solids separation remains a key part of compliance for many conventional systems.
• Process stability matters as much as nominal design capacity, especially where storm dilution, seasonal variation or industrial influent influence performance.

As always, design values such as sludge age, dissolved oxygen, MLSS and F/M ratio are site-specific. They should be treated as indicative operating tools rather than universal targets.

Who must provide secondary treatment

Under the recast directive, secondary biological treatment is mandatory for agglomerations of 2,000 p.e. and above.

The obligation is then extended to agglomerations of 1,000 p.e. and above by 31 December 2035, subject to transitional and exemption arrangements, including for certain coastal areas and for Bulgaria, Croatia and Romania.

A population equivalent, or p.e., is defined as the organic biodegradable load having a five-day biochemical oxygen demand of 60 g of oxygen per day. This definition is important because it links legal thresholds to organic load rather than to headcount alone.

For plant owners and designers, the consequence is that small and medium agglomerations may move into the regulated scope over time. That makes forward planning essential, especially where existing works are based on simpler treatment, limited process control or ageing secondary settlement assets.

The secondary effluent standards that still matter

Annex I of the directive sets the secondary-treatment effluent standards. These are the familiar end-of-pipe benchmarks that biological treatment plants must generally achieve when they fall within scope.

The standards are:

• BOD5: 25 mg/L, or 70-90% reduction
• COD: 125 mg/L, or 75% reduction
• Total suspended solids (TSS): 35 mg/L

These values matter because they link process performance to discharge consent and compliance monitoring. They also show that the directive is not only about infrastructure coverage. It remains focused on actual effluent quality and the ability of the treatment train to remove biodegradable organic matter and associated solids.

From an engineering perspective, meeting these values depends on several plant-specific factors:

• Influent strength and variability
• Hydraulic loading and wet-weather performance
• Aeration capacity and oxygen transfer
• Biomass retention and sludge settleability
• Secondary settlement performance or equivalent solids separation
• Return and waste sludge control

In many cases, the first compliance issue is not the biological reaction stage itself but the ability to keep solids in the system and achieve a stable separation stage.

Why the new directive matters for biological treatment

Although the directive covers the wider wastewater system, its main operational effect for many plants is to increase the strategic importance of biological treatment. That is true for both existing works and schemes that are still at concept or outline design stage.

The main reasons are:

• More agglomerations will be brought into secondary-treatment scope over time.
• Existing plants may need upgrades to maintain compliance under future loading or tighter permit conditions.
• Biological treatment assets must be assessed not just for today’s load, but for the future p.e. trajectory of the catchment.
• Secondary treatment remains the platform on which later nutrient and micropollutant requirements will sit.

For many facilities, this means reviewing whether the current process can absorb additional load, whether tankage and settlement have sufficient headroom, and whether control systems can maintain stable performance across seasonal conditions.

How secondary treatment fits with the wider EU framework

The new directive does not stop at secondary treatment. It also sets longer-term requirements for tertiary treatment, quaternary treatment and energy neutrality.

In outline:

• Tertiary treatment for nitrogen and phosphorus removal is required for plants of 150,000 p.e. and above by 2039.
• Tertiary treatment is also required for plants of 10,000 p.e. and above in areas at risk of eutrophication by 2045.
• Quaternary treatment for micropollutant removal is required for plants of 150,000 p.e. and above by 2045, with interim milestones in 2033 and 2039.
• Energy neutrality for the urban wastewater treatment sector is to be achieved by 2045.

For secondary treatment planning, the key point is that future upgrades are likely to build on the existing biological stage rather than replace the need for it. A plant that can reliably deliver secondary treatment today is better positioned for staged compliance later.

Practical implications for WWTP operators and engineers

For operators, the directive raises several practical questions that should be addressed early:

• Is the current biological stage consistently meeting BOD5, COD and TSS requirements?
• Is the works likely to come into scope for the 1,000 p.e. threshold by 2035?
• Are there wet-weather or seasonal limitations that could affect compliance?
• Is the secondary clarification stage a bottleneck under peak hydraulic or solids loading?
• Is there sufficient flexibility to accommodate future nutrient removal or advanced treatment upgrades?

For consulting engineers, the directive reinforces the need to check:

• Catchment p.e. projections and population growth assumptions
• Industrial contributions and load variability
• Available footprint for tank and settlement expansion
• Energy demand and resilience of aeration systems
• Options for phased upgrades without compromising current compliance

A good engineering review should not only ask whether the plant can pass a compliance test today, but whether its process train can evolve over the coming decade without major interruption.

Common misconceptions

A few points are often misunderstood when the directive is discussed:

• It does not mean every plant must immediately add tertiary or quaternary treatment.
• It does not replace the importance of secondary treatment; rather, it reaffirms it as the baseline biological requirement.
• It does not give a single plant-level design recipe, because national transposition and local permit conditions still matter.
• It does not change the fact that process performance depends on the whole treatment train, not on aeration alone.

In other words, the directive sets the framework, but each works still needs a site-specific engineering response.

How this applies to your plant

If your plant is already operating secondary treatment, the immediate task is to confirm whether the process is robust enough for current compliance and future obligations. If your agglomeration is close to a threshold, the planning horizon matters just as much as today’s consent limits.

A useful approach is to review:

• current p.e. and projected p.e.
• existing biological process configuration
• secondary settlement performance
• effluent monitoring history
• available upgrade space and process flexibility
• likely future nutrient or energy requirements

The right next step is usually a structured technical review that links legal scope to process reality. You can Start the Engineering Assessment to assess the implications for your plant and identify the most practical compliance pathway.

For a broader policy summary, see the related overview on the EU Directive page.